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Edited by Maurice MontalAbstract We have studied how N-type Ca2+ channels are
modulated by the metabotropic glutamate receptor 5a
(mGluR5a) in Xenopus oocytes. Stimulation of the receptor
with glutamate initiated two parallel responses, a rapid inhibition
followed by an upregulation of the Ca2+ current. Although a
subsequent stimulation did not upregulate the Ca2+ current, it
did still produce a reduction in the amplitude of the current. The
upregulation of Ca2+ channels was prevented by the protein
kinases inhibitor staurosporine and it was mimicked by the
activation of PKC with phorbol esters. In contrast, the inhibition
of the Ca2+ current was insensitive to staurosporine. These
results show that mGluR5a exerts a bi-directional inﬂuence on
Ca2+ channels, which may explain how group I mGluRs
facilitate and inhibit glutamate release at central synapses.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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The signaling pathways activated by group I metabotropic
glutamate receptors (mGluR1 and mGluR5) include those
involving phospholipase A [1], adenylyl cyclase [1], as well as
others that inhibit Ca2þ channels [2,3]. These receptors are also
coupled to phospholipase C (PLC), which mediates the hy-
drolysis of phosphoinositide (PI) to inositol 1,4,5-trisphos-
phate (IP3) and diacylglycerol (DG) [1,4,5]. As the
consequence of activating such signaling pathways, group I
mGluRs can either reduce or increase excitatory synaptic
transmission in the CA1 hippocampal area [6–9]. Indeed, we
have shown that facilitation of transmitter release is associated
with an increase in diacylglycerol and in PKC activity, leading
to an enhanced inﬂux of Ca2þ [10]. In contrast, the inhibition
of transmitter release is independent of this signaling pathway
and linked to a decrease in the inﬂux of Ca2þ [10]. We have
proposed that both these actions are mediated by the same
mGluR that undergoes a switch in activity upon exposure to
its agonist [9,10]. Therefore, we would expect that the selective
fading of speciﬁc signaling pathways has striking eﬀects on the* Corresponding author. Present address: Departamento de
Bioquimica, Facultad de Veterinaria, Universidad Complutense,
28040 Madrid, Spain. Fax: +34-91-394-39-09.
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doi:10.1016/j.febslet.2004.09.053physiological activity of these receptors. Interestingly, it is well
known that the hydrolysis of PI triggered by group I mGluRs
desensitizes when agonist stimulation is prolonged [10–13] and
that this is largely due to the phosphorylation of the receptor
at multiple sites by PKC [13].
Given the importance of Ca2þ channels in the control of
glutamate release, we have investigated whether group I
mGluRs can diﬀerentially modulate these channels by acti-
vating diﬀerent signaling pathways. As a result, we found that
PKC-dependent and independent signaling by mGluR5a ex-
erts bi-directional control of Ca2þ channel activity, which
underlies group I mGluR-induced facilitation and inhibition of
glutamate release at synapses.2. Materials and methods
2.1. Expression of mGluR5a and Ca2þ channels in Xenopus oocytes
Adult Xenopus laevis were obtained from the CNRS Xenopus facility
(Montpellier, France) and we obtained the oocytes from females as
described previously [14]. After defolliculation, oocytes were allowed
to recover for 24 h at 17 C in standard ND96 medium buﬀered to pH
7.4 (96 mM NaCl, 2 mM KCl, 2 mM MgCl2, 1.8 CaCl2 and 10 mM
HEPES), and supplemented with 2.5 mM sodium pyruvate, 0.1 mg/ml
streptomycin and 100 U/ml penicillin. The cRNAs were injected in 50
nl (6–15 ng/oocyte) and the oocytes were maintained in standard me-
dium at 17 C for 2–6 days prior to performing electrophysiological
recordings.
2.2. RNA synthesis
Prior to RNA synthesis, the plasmids containing the cDNAs were
linearized: the plasmid containing the mGluR5a cDNA with XbaI
(pBluescript SK-); the plasmid with the cDNA encoding the a1B-b
subunit (Cav 2.2) of N-type Ca
2þ channels with VspI (pBSTA); and
that with the b3 subunit of Ca2þ channels with EcoRI (pcDNA3). The
cRNAs were then transcribed in vitro from these linearized plasmids
using the mMessage mMachine kit from Ambion (Austin, TX, USA).
2.3. Solutions and data analysis
Two-electrode voltage-clamp recordings were performed using a
Geneclamp 500 ampliﬁer (Axon Instruments, Union City, CA), and
analyzed with pCLAMP and Axoscope software (Axon Instruments).
Cells were voltage clamped at )60 mV with the aid of two micro-
electrodes ﬁlled with 3 M KCl with a resistance typically in the range of
0.5–1.5 MX. To isolate the Ca2þ currents, recordings were performed
in a solution containing (in mM) NaCl 96, KCl 2, MgCl2 2, BaCl2 10,
TEA 10, and HEPES 10, supplemented with niﬂumic acid (0.4 mM) to
block Cl channels. On occasions, Ba2þ currents showed rundown,
which was corrected oﬀ-line by subtracting the slope resulting from the
linear ﬁt to the time course plot. For measuring purposes, leak currents
were subtracted from original recordings.
All drugs were obtained from Sigma (St. Louis, MO), except for
staurosporine and collagenase D, which were supplied by Boehringer
Mannheim (Germany). The VspI and EcoRI restriction enzymes wereation of European Biochemical Societies.
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Fig. 1. Desensitization of mGluR5a-induced responses. (A) Electro-
physiological responses to paired applications of 100 lM glutamate at
the intervals indicated from a single oocyte injected with mGluR5
cRNA (horizontal bars). Note the complete desensitization of the re-
sponse induced by the ﬁrst exposure to glutamate and its slow recov-
ery. (B) Bars represent means SEM of the Ca2þ-dependent Cl
current amplitude induced by an initial (n¼ 25) and a subsequent
application of glutamate delivered 2–5 min (n¼ 24) or 20–30 min
(n¼ 4) after the ﬁrst one.3. Results
3.1. The Ca2þ-dependent Cl current induced by activation of
mGluR5a
The activation of receptors coupled to PLC and PI hydro-
lysis enhances the production of IP3 and diacylglycerol. Whilst
the latter activates protein kinase C, IP3 induces the release of
calcium from intracellular stores, which in oocytes triggers an
endogenous Ca2þ-dependent Cl current. Therefore, the am-
plitude of this current can be taken as an estimate of the ac-
tivity of G protein-coupled receptors linked to PI hydrolysis
[15]. When we expressed mGluR5a in oocytes, a single pulse of
glutamate (100 lM, 1 min) induced a transient inward current
due to the opening of endogenous Ca2þ-dependent Cl chan-
nels (3–4 lA in amplitude; Fig. 1A). This glutamate pulse
desensitized the receptors, since a second addition of glutamate
shortly afterwards (e.g., 2 min) produced little or no eﬀect
(Fig. 1A). However, when glutamate was applied 30 min later,
the mGluR5a-induced current was largely recovered. Indeed,
the reduction in the response to a second pulse of glutamate
delivered 2–5 min after the ﬁrst was 72.3 6.5% (n¼ 24) but
when the second pulse was administered 20–30 min later, the
response only decreased by 21.3 7.1% (n¼ 4; Fig. 1B). As
shown previously, the decrease of the Cl mediated response is
due to receptor desensitization rather than to the inactivation
of Cl channels or the depletion of intracellular Ca2þ stores
[13]. These data indicate that the recovery from agonist-in-
duced desensitization of recombinant mGluR5a receptors in
oocytes is slow and is similar to that previously seen in brain
preparations [10,12].
3.2. The modulation of N-type Ca2þ channels by mGluR5a is
bi-directional
A large body of evidence indicates that transmitter release is
facilitated by mGluR-mediated induction of PI hydrolysis and
PKC activation, while the inhibition of release is mostly in-
dependent of this signaling pathway [9,10,12,16,17]. Since the
extent of neurotransmitter release is established through Ca2þ
channel activity, we determined whether mGluR5 could exert a
bi-directional inﬂuence on these channels. Oocytes were in-
jected with cRNAs encoding for both the N-type Ca2þ channel
subunits and mGluR5a receptors. The Ca2þ channels were
then opened by applying 60 ms voltage steps to +20 mV from a
holding potential of )70 mV and the current carried by Ba2þ
was measured. Using this protocol, we observed a rapid inhi-
bition of the Ca2þ current upon application of glutamate (100
lM, 1 min; Fig. 2C) that subsequently faded and promoted a
clear facilitation. On average, glutamate initially inhibited
Ca2þ channels by 22.4 3.4% (n¼ 6; measured at the peak of
inhibition 20–30 seconds after glutamate addition), while the
subsequent facilitation was 16.9 3.3% (n¼ 6; measured 2 min
after glutamate addition: Fig. 2D). However, a subsequent
application of glutamate provoked a sustained inhibition of
the Ba2þ current with no further facilitation. The inability of
this second glutamate application to facilitate the Ba2þ current
was not due to the Ca2þchannels having already reached a
maximum, since receptor independent activation of PKC with
phorbol esters further enhanced Ba2þ currents. Indeed, theapplication of the phorbol ester PDBu (1 lM, 1 min) induced a
slow developing upregulation of the Ba2þ current that gluta-
mate was still capable of reversibly inhibiting (Fig. 2C). Thus,
it seems likely that in response to a pulse of glutamate, two
partially overlapping processes are set in motion: a rapid in-
hibition that depends on the presence of the agonist; and a
more slowly developing and long-lasting upregulation of Ca2þ
channels.
The dual modulation of Ca2þ channel activity by mGluR5a
was also observed after a longer application of glutamate (4
min; Fig 3A). Under these conditions, glutamate rapidly in-
hibited the Ba2þ current by 19.0 3.8% (n¼ 4; Fig. 3B),
however, a clear facilitation of the Ba2þ current developed
afterwards (17.0 2.4%, n¼ 4, measured 2 min after the ap-
plication of glutamate commenced: Fig. 3B).
It appeared that the inhibition of Ca2þ channels was inde-
pendent of the capacity of mGluR to activate Cl channels. In
contrast, the facilitation of the Ca2þ current occurs when
mGluR5a can activate Ca2þ dependent Cl channels. These
data indicate that the facilitation and the inhibition of the N-
type Ca2þ channels may be mediated by mGluR5a signaling
through two distinct pathways: a PI hydrolysis-dependent and
PI hydrolysis-independent pathway, respectively. To conﬁrm
this hypothesis, we ﬁrst examined the inﬂuence that G-proteins
might have on these events. The modulation of Ca2þ channels
by mGluR5a was blocked by pertussis toxin (PTX, 500 ng/ml;
overnight incubation; Fig. 3C). In the presence of PTX, the
mean inhibition of the Ba2þ current was 3.1 1.1% (n¼ 5),
while the facilitation of the Ba2þ current was 0.5 0.5% (n¼ 5;
Fig. 3D). Thus, in contrast to the coupling of mGluR5a to Gq
found in neuronal preparations [18], calcium channel modu-
lation by mGluR5a in oocytes appeared to be largely mediated
by the PTX-sensitive Gi or Go subtypes of G proteins [19].
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Fig. 2. mGluR5a induces the bi-directional modulation of N-type Ca2þ channels. (A) A family of Ba2þ currents in oocytes injected with cRNA for
a1B-b (Cav 2.2) and b3, induced by 10 mV steps from a holding potential at )70 mV. (B) The current–voltage relationship for Ba2þ-currents. (C) Time-
course of the changes in the amplitude of the Ba2þ currents (60 ms pulses to +20 mV) in mGluR5a-expressing oocytes following repetitive application
of glutamate (100 lM, 1 min). When indicated, PDBu (1 lM, 1 min) was introduced into the recording chamber. (D) Fractional inhibition and
facilitation after an initial and second pulse of glutamate. Bars are meansSEM from six experiments. Measurements were taken 20 s (open bars)
and 2 min (shaded bars) after glutamate addition in each case.
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in this bi-directional modulation of N-type Ca2þ channels,
oocytes were treated with the broad-spectrum protein kinase
inhibitor staurosporine (5 lM for 2 h). Interestingly, the ad-
dition of glutamate to staurosporine-treated oocytes caused a
sustained inhibition of the Ba2þ current, which did not fade.
Indeed, in these experiments the Ba2þ current was diminished
by 23.33 2.4% and 19.3 2.7%, when measured 20 s and 2
min after glutamate application (n¼ 3; Fig. 3E and F). Fur-
thermore, although the activation of PKC with PDBu (1 lM, 1
min) enhanced the Ca2þ current (46.8 7.6%; n¼ 5; measured
5 min after the addition of glutamate), this eﬀect was com-
pletely abolished by staurosporine (0.60 0.70%; n¼ 4: data
not shown). These results provide further evidence that the
modulation of N-type Ca2þ channels by mGluR5a involves
two distinct pathways: one that is PKC-dependent that upre-
gulates Ca2þ channel activity; and the other that is PKC-
independent that provokes the inhibition of Ca2þ channel
activity. The upregulation of the Ca2þ current is only observed
after the ﬁrst application of the agonist, since it desensitizes
and becomes tolerant to subsequent stimulation. On the other
hand, the second pathway does not desensitize and could be
readily activated by repeated applications of the agonist.4. Discussion
The results presented here indicate that mGluR5a activates
two independent pathways that modulate N-type Ca2þ chan-
nels. Speciﬁcally, mGluR5a activates a PKC-dependent facil-
itatory pathway and a PKC-independent inhibitory pathway.
Moreover, Gi/o proteins are involved in both the facilitation
and inhibition of N-type Ca2þ channels, since both activitiesare sensitive to PTX in oocytes. Facilitation of the Ca2þ cur-
rent was associated with the ability of the receptor to promote
hydrolysis of PI (i.e., PKC stimulation), whilst the inhibition
of Ca2þ channels was observed even when the pathway leading
to PI hydrolysis was desensitized.
In oocytes expressing mGluR5a, stimulation of PI hydro-
lysis induces the opening of endogenous Ca2þ-dependent Cl
channels as a consequence of the IP3-induced release of in-
tracellular Ca2þ. The accumulation of IP3 must be paralleled
by the synthesis of diacylglycerol, which in turn would activate
PKC. When we challenged the mGluR5a receptor with glu-
tamate, Ca2þ channel activity was slowly facilitated. However,
a second pulse of glutamate was ineﬀective in activating Ca2þ-
dependent Cl channels, indicating that no PI hydrolysis or
PKC activation occurred (see [13]). At the beginning of the
ﬁrst glutamate pulse, the Ca2þ current was initially inhibited
and this inhibition was clearly unmasked during the second
pulse. Although abolished by exposure to PTX, this inhibitory
activity was resistant to the protein kinases inhibitor stauro-
sporine. Hence, it seems likely that this inhibition results from
a direct interaction between the G-protein bc component and
the pore-forming a1 subunit of the channel [20–22], and that
the slower facilitation probably arises from the PKC-mediated
phosphorylation of Ca2þ channels [23]. Indeed, the facilitation
of the Ca2þ currents by the initial application of glutamate was
mimicked by exposure to phorbol esters and prevented by the
general protein kinase inhibitor staurosporine. These results
lead us to conclude that the bi-directional modulation of N-
type Ca2þ channels is the consequence of dual signaling initi-
ated by mGluR5a.
The desensitization of the mGluR5 provoked Ca2þ-depen-
dent Cl current response is directly related to the phosphor-
ylation of this receptor at PKC consensus sites in oocytes [13].
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Fig. 3. Changes in Ba2þ currents (evoked by 60 ms pulses to +20 mV) induced by a long (4 min) application of glutamate in control oocytes (A, B),
and in oocytes treated with pertussis toxin (1 lg/ml, 19 h) (C, D) or staurosporine (5 lM, 2 h) (E, F). Bars are means SEM of Ba2þ current
amplitudes, measured 20 s (arrow, open bars) and 2 min (arrowhead, shaded bars) after glutamate addition, from three to ﬁve experiments.
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ceptor diﬀerentially aﬀects the distinct signaling pathways.
Indeed, a number of ﬁndings indicate that this dual signaling
by mGluR5a could be switched on and oﬀ by selective de-
sensitization of one of the pathways. For instance, in HEK 293
cells expressing mGluR1, the activation of aPKC selectively
inhibits glutamate-induced stimulation of IP3 production, but
does not aﬀect receptor signaling via cAMP [24]. A similar
mechanism has also been proposed for b2-adrenergic recep-
tors, whose coupling to Gs or Gi proteins is switched by re-
ceptor phosphorylation by PKA, thereby modulating receptor
signaling [25]. Similarly, in cultured astrocytes, mGluR5 en-
hances PI hydrolysis/Ca2þ signaling and the activation of the
extracellular signal-regulated kinase 2 (ERK2) [26]. In this
system, PKC plays an important role in the rapid desensiti-
zation of PI hydrolysis/Ca2þ signaling, but not in ERK2
phosphorylation.
The bi-directional modulation of N-type Ca2þ channels by
mGluR5a accounts for the dual modulation of synaptictransmission in the CA1 hippocampal region. Here, perfusion
with the group I mGluR agonist DHPG initially facilitates but
then inhibits glutamate release [9]. However, the initial inhi-
bition and subsequent potentiation of the N-type Ca2þ current
observed in oocytes do not ﬁt well with the sequential eﬀect
that group I mGluR agonists have in synaptic transmission in
slices [9] and glutamate release in synaptosomes [10]. One
possible explanation for this discrepancy could be that the
exogenous activation of mGluRs in slices or synaptosomes is
not attained as rapidly as in oocytes, precluding the temporal
resolution of the initial inhibition. Alternatively, the more ra-
pid onset of Ca2þ channel inhibition compared to the facili-
tation observed in oocytes could well reﬂect the failure of the
receptor to couple optimally to the facilitatory pathway in this
preparation.
Whatever the reason, the consequence of the dual signaling
by mGluR5a accounts for the observed bi-directional modu-
lation of synaptic transmission triggered by group I mGluR
agonists. Group I mGluRs share signaling systems in that they
432 J. Sanchez-Prieto et al. / FEBS Letters 576 (2004) 428–432are coupled to similar G proteins. Therefore, the bi-directional
modulation of N-type Ca2þ channels by these receptors may
be a more generalized phenomenon.
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